Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S2BV
|
||||
Former ID |
DNC000694
|
||||
Drug Name |
Glitazone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Phase 4 | [522750] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H9NO3S
|
||||
CAS Number |
CAS 2295-31-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | Agonist | [534997] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.